Breaking News

Nurses capitalize on new clout in D.C.; first pig heart transplant recipient dies

 

Daily Recap

Nurses, more powerful and visible after Covid, capitalize on new clout in Washington

By Lev Facher

Spencer Platt/Getty Images

Empowered by their role fighting Covid, nurses are planning a march on Washington, and pushing lawmakers and Biden to improve their pay.

Read More

STAT+: Gilead's Dan O'Day is pharma's most charming executive — but with his deals falling apart, charm may not be enough

By Matthew Herper

Emilie Pickering for STAT

The news that Gilead dropped about its drug breast cancer drug Trodelvy was the latest in a string of disappointments.

Read More

First person to receive a pig heart transplant dies after two months

By Lauran Neergaard and Carla K. Johnson — Associated Press

University of Maryland School of Medicine

Doctors didn't give an exact cause of death for David Bennett, saying only that his condition had begun deteriorating several days earlier.

Read More

STAT+: Dozens of towns and counties object to 'hush money' tied to Purdue opioid settlement

By Ed Silverman

Toby Talbot/AP

The towns and counties argue that nearly $277 million of the settlement will go to eight states that negotiated a revised $6 billion deal.

Read More

Opinion: Hospitals need to get ahead of regulations on climate change

By Sierra Nesbit and Jenna Phillips

Cherry/Getty Images

Hospitals and other health care delivery organizations need to assess and mitigate their contributions to climate change now.

Read More

Opinion: Ignoring behavioral and social sciences undermines the U.S. response to Covid-19

By Judith D. Auerbach and Andrew D. Forsyth

Adobe

Efforts to stop Covid-19 have failed in part because they have ignored insights and expertise from the behavioral and social sciences.

Read More

Wednesday, March 9, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments